(Q51034962)

27 March 2018

title

Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats. (English)

1 reference

27 March 2018

author name string

M Shamsul Ola

1

1 reference

27 March 2018

Mohammed M Ahmed

2

1 reference

27 March 2018

Hatem M Abuohashish

3

1 reference

27 March 2018

Salim S Al-Rejaie

4

1 reference

27 March 2018

Abdullah S Alhomida

5

1 reference

27 March 2018

publication date

27 April 2013

1 reference

27 March 2018

published in

Neurochemical Research

1 reference

27 March 2018

volume

38

1 reference

27 March 2018

issue

8

1 reference

27 March 2018

page(s)

1572-1579

1 reference

27 March 2018

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Prospects for angiotensin receptor blockers in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

The renin-angiotensin system and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Renal and retinal effects of enalapril and losartan in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Transcriptional upregulation of brain-derived neurotrophic factor in rostral ventrolateral medulla by angiotensin II: significance in superoxide homeostasis and neural regulation of arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Hypertension downregulates the expression of brain-derived neurotrophic factor in the ischemia-vulnerable hippocampal CA1 and cortical areas after carotid artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Neurovascular signalling defects in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Effect of CNTF on retinal ganglion cell survival in experimental glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Neurodegeneration and neuroprotection in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Deletion of angiotensin II type 1 receptor gene attenuates chronic alcohol-induced retinal ganglion cell death with preservation of VEGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Angiotensin and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1058-4

Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats

21 January 2018

1 reference

12 December 2020

Angiotensin II and its receptor subtypes in the human retina

1 reference

12 December 2020

Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome

1 reference

12 December 2020

Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas

1 reference

12 December 2020

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

12 December 2020

Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers

1 reference

12 December 2020

Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1R) Blocker, Telmisartan, via Modulating AT1R and AT2R Signaling in Retinal Inflammation

1 reference

12 December 2020

Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT₁ receptor in the rostral ventrolateral medulla of hypertensive rats

1 reference

12 December 2020

Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway

1 reference

12 December 2020

Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis

1 reference

12 December 2020

Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels

1 reference

12 December 2020

10.1007/S11064-013-1058-4

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018